Emerging Trends to Reshape the Synthetic Blood Substitutes And Blood Products Market: Advancements In Lab-grown Blood Vessels For Trauma Care as a Key Influencer

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Synthetic Blood Substitutes And Blood Products Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of synthetic blood substitutes and blood products has experienced swift expansion lately. The growth is predicted to progress from $6.55 billion in 2024, to reach $7.6 billion in 2025, with a compound annual growth rate (CAGR) of 16.0%. The expansion during the historic period was driven by factors such as the rise in the elderly population, escalating need for blood transfusions, a surge in the demand for safe and unpolluted blood, increasing knowledge of potential hazards from blood transfusion, and a heightened emphasis on emergency healthcare.

Synthetic Blood Substitutes And Blood Products Market Size Forecast: What's the Projected Valuation by 2029?
The market for synthetic blood substitutes and blood products is anticipated to experience swift expansion in the upcoming years, increasing to a value of $13.63 billion in 2029 with a compound annual growth rate (CAGR) of 15.7%. The projected growth during the forecast period can be linked to its widening use in military operations and disaster reliefs, enhanced knowledge regarding alternative blood substitutes, elevated occurrence rate of blood-related illnesses, and an increase in trauma and emergency surgeries. During the forecasted period, key trends will encompass the creation of hemoglobin-based oxygen carriers, regulatory endorsements and research, progress in biotechnology, developments in regenerative medicine, and the incorporation of Artificial Intelligence (AI).

View the full report here:
https://www.thebusinessresearchcompany.com/report/synthetic-blood-substitutes-and-blood-products-global-market-report

What Are the Drivers Transforming the Synthetic Blood Substitutes And Blood Products Market?
The increase in chronic diseases is anticipated to drive the expansion of the synthetic blood substitutes and blood products market. Chronic diseases are enduring health issues that can be managed, but not completely cured, often persisting more than a year and demand constant medical attention. Several factors, including aging populace, unhealthy lifestyles, and increased longevity contribute to the rise in prevalence of chronic diseases. Synthetic blood substitutes and blood products play a key role in controlling chronic disease prevalence by confronting particular issues tied to blood loss, anemia, and organ functioning, which are typical in patients suffering from chronic diseases. For example, the Australian Institute of Health and Welfare, a government agency in Australia, revealed in June 2024 that the mortality rate due to chronic diseases in Australia climbed from 459 deaths per 100,000 population in 2021 to 490 in 2022. Consequently, the mounting prevalence of chronic diseases stimulates the growth of the synthetic blood substitutes and blood products market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21294&type=smp

What Are the Key Trends Driving Synthetic Blood Substitutes And Blood Products Market Growth?
Leading firms within the synthetic blood substitutes and blood products market are placing emphasis on developing groundbreaking products such as lab-grown blood vessels. This is in a bid to enhance emergency medical healthcare, boost the results of trauma treatment, and respond to the worldwide scarcity of donor blood and tissues. Engineered from human or artificial cells, lab-grown blood vessels mimic the design and working of natural arteries and veins and are made for use in trauma repair, dialysis and cardiovascular surgery. Humacyte Global, Inc., a clinical-stage biotechnology platform based in the US, for example, received U.S. Food and Drug Administration (FDA) approval in December 2024 for Symvess. This is a ready-made, bioengineered blood vessel implant for trauma patients requiring immediate revascularization. It provides a safer substitute to vein harvesting or synthetic grafts. Designed for widespread use, Symvess restores blood circulation and salvages limbs following critical injuries.

Which Segments in the Synthetic Blood Substitutes And Blood Products Market Offer the Most Profit Potential?
The synthetic blood substitutes and blood products market covered in this report is segmented -

1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users

Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21294&type=smp

Which Firms Dominate the Synthetic Blood Substitutes And Blood Products Market by Market Share and Revenue in 2025?
Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.

Which Regions Offer the Highest Growth Potential in the Synthetic Blood Substitutes And Blood Products Market?
North America was the largest region in the synthetic blood substitutes and blood products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21294

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

"

#Reach Out to Us#

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.